Literature DB >> 7086356

Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.

D E Chenoweth, M G Goodman, W O Weigle.   

Abstract

Human C5a anaphylatoxin is known to be a potent mediator of the acute inflammatory response. It serves to trigger a wide variety of neutrophil responses after binding to a specific cellular receptor. We have now demonstrated that this bioactive glycopolypeptide is also bound to a specific receptor found on murine resident peritoneal macrophages, thioglycollate-induced exudate macrophages, and the murine cell line P388D1. The apparent Kd of the C5a receptors. Resident macrophages appear to have an average of 2 x 10(5) binding sites per cell, whereas thioglycollate- induced cells have only 4-5 x 10(4) binding sites. The continuous cell line P388D1 is intermediate between these two cell types, exhibiting 8-10 x 10(4) C5a receptors per cell. Neither murine lymphocytes nor the parent cell line P388 displays a measurable number of C5a receptors. Macrophage receptor-C5a binding interactions are followed by cellular uptake and degradation of 125I-C5a, much as is observed with neutrophils. As demonstrated in another paper, binding of C5a to macrophages results in augmentation of the primary humoral immune response as well as enhancement of mixed lymphocyte reactions. These observations suggest that C5a should not only be considered as an acute inflammatory mediator but as an immunopotentiating modulator as well, thus serving as a critical link between complement activation and subsequent immune responses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086356      PMCID: PMC2186737          DOI: 10.1084/jem.156.1.68

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

3.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

4.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

5.  Release of histamine from rat mast cells by the complement peptides C3a and C5a.

Authors:  A R Johnson; T E Hugli; H J Müller-Eberhard
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

6.  Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.

Authors:  H N Fernandez; T E Hugli
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

7.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

8.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

9.  Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.

Authors:  R Snyderman; M C Pike; D McCarley; L Lang
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.

Authors:  M D Barker; P J Jose; T J Williams; D R Burton
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

4.  Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

Authors:  M C Cerquetti; D O Sordelli; J A Bellanti; A M Hooke
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

5.  Mechanism of action of the group A streptococcal C5a inactivator.

Authors:  D E Wexler; D E Chenoweth; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 7.  Biological properties of human C5a: selected in vitro and in vivo studies.

Authors:  K B Yancey
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

8.  Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.

Authors:  H D Perez; D E Chenoweth; I M Goldstein
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.

Authors:  Lei Sun; Ren-Feng Guo; Hongwei Gao; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2009-07-20       Impact factor: 5.191

10.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.